Article first published online: 2 MAY 2011
Copyright © 2011 American Association for the Study of Liver Diseases
Volume 53, Issue 6, pages 1943–1958, June 2011
How to Cite
Omar, H. A., Chou, C.-C., Berman-Booty, L. D., Ma, Y., Hung, J.-H., Wang, D., Kogure, T., Patel, T., Terracciano, L., Muthusamy, N., Byrd, J. C., Kulp, S. K. and Chen, C.-S. (2011), Antitumor effects of OSU-2S, a nonimmunosuppressive analogue of FTY720, in hepatocellular carcinoma. Hepatology, 53: 1943–1958. doi: 10.1002/hep.24293
Potential conflict of interest: Nothing to report.
Supported by Public Health Service Grants R21 CA133710 and R01 CA112250 from the National Cancer Institute of the National Institutes of Health (to C.S.C.), by the Lucius A. Wing Chair Fund of The Ohio State University Medical Center (to C.S.C.), and a Specialized Center of Research grant from the Leukemia and Lymphoma Society (to C.S.C., N.M., and J.C.B.).
- Issue published online: 25 MAY 2011
- Article first published online: 2 MAY 2011
- Accepted manuscript online: 9 MAR 2011 12:56PM EST
- Manuscript Accepted: 1 MAR 2011
- Manuscript Received: 21 SEP 2010
Additional Supporting Information may be found in the online version of this article.
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.